News & Events

Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that Dalton Pharma Services (Dalton) has completed the good manufacturing practice (GMP) glass vial filling stage for cilastatin, the Company’s second drug candidate for preventing acute kidney injury (AKI).

Pharmaceutical manufacturing company, Dalton Pharma Services (a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a fully automated state-of-the-art high-speed aseptic powder filling line to expedite the delivery of drugs to market in a more compliant, efficient, and economical manner.

Dalton recently hosted an academic tour for students from McGill University, showcasing our expanding state-of-the-art facilities and our commitment to nurturing future scientific talent.

The capital expansion plan includes a new state-of-the-art, fully automated cGMP sterile filling line with the flexibility to fill vials, syringes, and cartridges under isolator technology.

Dalton Pharma Services is pleased to announce its recent approval for the Cannabis Analytical Test Licence from Health Canada under the Cannabis Act and Cannabis Regulations.

LSALT Peptide has recently entered the Canadian Treatments for COVID-19 Trial. Dalton Pharma Services has supported the development of LSALT Peptide through our fill and finish services in our state-of-the-art manufacturing facility.

TransMedics OCS Liver System was recently granted FDA premarket approval. Dalton Pharma Services is thrilled to be supporting the commercialization of this important novel technology and to be part of TransMedics success.

Diamond Therapeutics Hires Industry Veteran David Brown, PhD, to Further Advance Formulation of Psilocybin by Dalton Pharma

Cardiol Therapeutics’ Cortalex™ CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

Dalton is a Health Canada approved, and FDA inspected, GMP contract provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries.